A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Clinical trial NCT02750410 · COMPLETED
Trial details
- NCT number
- NCT02750410
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-06-18
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.